ISBN: 9780471722793

Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrate… Altro …

Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies. Drugs-From Discovery to Approval presents a clear, step-by-step overview of the entire process. Using simple language, this comprehensive guide introduces basic concepts, then moves on to discuss disease target selection and the discovery processes for both small and large molecule drugs. Subsequent chapters explain preclinical studies, clinical trials, regulatory issues, good manufacturing practices (GMPs), and perspectives on the future. Coverage also includes: * A helpful listing of current FDA and European guidelines * A special section on regulatory authorities and processes in Japan and China * Rich illustrations throughout, including more than ninety figures and tables * Useful appendices on the history of drug discovery and development * Representative examples of drug mechanisms in action Written for professionals in the pharmaceutical industry, and readily accessible for students of pharmacy or medicine and others interested in drug discovery, Drugs-From Discovery to Approval represents a practical and approachable reference on this important process.; PDF; Business,Finance and Law > Industry & industrial studies > Manufacturing industries > Pharmaceutical, Cambridge University Press<

ISBN: 9780471722793

Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrate… Altro …

Statistics show that out of five thousand compounds with initial promise, five will go into human clinical trials, and only one will become an approved drug. This tiny fraction illustrates the huge complexities involved in bringing a drug to market, a process that brings together scientific research, medical ethics, business, and various regulatory agencies. Drugs-From Discovery to Approval presents a clear, step-by-step overview of the entire process. Using simple language, this comprehensive guide introduces basic concepts, then moves on to discuss disease target selection and the discovery processes for both small and large molecule drugs. Subsequent chapters explain preclinical studies, clinical trials, regulatory issues, good manufacturing practices (GMPs), and perspectives on the future. Coverage also includes: * A helpful listing of current FDA and European guidelines * A special section on regulatory authorities and processes in Japan and China * Rich illustrations throughout, including more than ninety figures and tables * Useful appendices on the history of drug discovery and development * Representative examples of drug mechanisms in action Written for professionals in the pharmaceutical industry, and readily accessible for students of pharmacy or medicine and others interested in drug discovery, Drugs-From Discovery to Approval represents a practical and approachable reference on this important process.; PDF; Business,Finance and Law > Industry & industrial studies > Manufacturing industries > Pharmaceutical, Wiley<

ISBN: 9780471722793

Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates … Altro …

Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates the hugecomplexities involved in bringing a drug to market, a process thatbrings together scientific research, medical ethics, business, andvarious regulatory agencies. Drugs-From Discovery to Approval presents a clear, step-by-stepoverview of the entire process. Using simple language, thiscomprehensive guide introduces basic concepts, then moves on todiscuss disease target selection and the discovery processes forboth small and large molecule drugs. Subsequent chapters explainpreclinical studies, clinical trials, regulatory issues, goodmanufacturing practices (GMPs), and perspectives on the future. Coverage also includes:* A helpful listing of current FDA and European guidelines* A special section on regulatory authorities and processes inJapan and China* Rich illustrations throughout, including more than ninety figuresand tables* Useful appendices on the history of drug discovery anddevelopment* Representative examples of drug mechanisms in actionWritten for professionals in the pharmaceutical industry, andreadily accessible for students of pharmacy or medicine and othersinterested in drug discovery, Drugs-From Discovery to Approvalrepresents a practical and approachable reference on this importantprocess. eBooks Medical~~Other Branches of Medicine~~Pharmacology Drugs~~EBook~~9780471722793~~Rick Ng Drugs<

ISBN: 9780471722793

Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates … Altro …

Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates the hugecomplexities involved in bringing a drug to market, a process thatbrings together scientific research, medical ethics, business, andvarious regulatory agencies.Drugs-From Discovery to Approval presents a clear, step-by-stepoverview of the entire process. Using simple language, thiscomprehensive guide introduces basic concepts, then moves on todiscuss disease target selection and the discovery processes forboth small and large molecule drugs. Subsequent chapters explainpreclinical studies, clinical trials, regulatory issues, goodmanufacturing practices (GMPs), and perspectives on the future.Coverage also includes:* A helpful listing of current FDA and European guidelines* A special section on regulatory authorities and processes inJapan and China* Rich illustrations throughout, including more than ninety figuresand tables* Useful appendices on the history of drug discovery anddevelopment* Representative examples of drug mechanisms in actionWritten for professionals in the pharmaceutical industry, andreadily accessible for students of pharmacy or medicine and othersinterested in drug discovery, Drugs-From Discovery to Approvalrepresents a practical and approachable reference on this importantprocess. E-Book, [PU: Wiley]<

ISBN: 9780471722793

From Discovery to Approval Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This… Altro …

From Discovery to Approval Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates the hugecomplexities involved in bringing a drug to market, a process thatbrings together scientific research, medical ethics, business, andvarious regulatory agencies. Drugs: Statistics show that out of five thousand compounds with initialpromise, five will go into human clinical trials, and only one willbecome an approved drug. This tiny fraction illustrates the hugecomplexities involved in bringing a drug to market, a process thatbrings together scientific research, medical ethics, business, andvarious regulatory agencies. Biotechnologie i. d. Biowissenschaften Biotechnology Biowissenschaften Chemie Chemistry Life Sciences Medical Science Medizin Pharmaceutical & Medicinal Chemistry Pharmacology & Pharmaceutical Medicine Pharmakologie Pharmakologie u. Pharmazeuti, John Wiley & Sons<